In-licensing, Acquisitions
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20
NCT06547112
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
Phase: Phase 1
Role: Collaborator
Start: Oct 31, 2024
Completion: Aug 19, 2025
Loading map...